A protein in men can determine if they are likely to have a low or high risk of surviving prostate cancer, a new study finds.
The protein is prostate-specific antigen, or PSA, which is made by the prostate gland.
If men with prostate cancer have a low PSA level after drug therapy, they are more likely to survive the cancer than men with high PSA levels, a research team at the University of Michigan found.
Prostate-cancer patients with low PSA levels after androgen-deprivation therapy, which blocks male hormones, had only a 75 percent greater chance of surviving than men with higher PSA levels, reported the study, published in the Aug. 20 issue of the Journal of Clinical Oncology.
Patients with undetectable PSA levels had an 80 percent chance.
The median survival was 13 months for high-PSA patients; 44 months for low-PSA patients; and 75 months for patients with nearly undetectable PSA levels; the study said.
New Delhi, November 18 -- Since its outbreak in June this year, the H1N1 influenza has taken a widespread toll. With four more H1N1 deaths in India, the toll goes up to 530, as per an official statement.
We seeks happiness even as it continues to elude many of us. However, the fact is that if we focus our attention on other things and not strive for happiness itself, we will experience this emotion more often.
You have just met your Mr. Right and with all your womanly intuition you feel that he is the one you have been waiting for. You are excited, can`t stop smiling and your cheeks turn red the moment he enters.
Disclaimer: The views and ideas expressed by medical experts on themedguru.com are their own, and not that of the website or its management. TheMedGuru advises users to check with their certified experts for their healthcare needs.
The comments and views posted by readers are their own and not that of the website or its management. Please see our 'Terms of Service' for details.
Post new comment